Sandip Kapadia
2021 - Intercept Pharmaceuticals
Compensation breakdown
| Option Awards | $461,335 |
|---|---|
| Salary | $117,513 |
| Stock Awards | $1,022,142 |
| Other | $59,674 |
| Total | $1,660,664 |
Kapadia received $1M in stock awards, accounting for 62% of the total pay in 2021.
Kapadia also received $461.3K in option awards, $117.5K in salary and $59.7K in other compensation.
Rankings
In 2021, Sandip Kapadia's compensation ranked 6,808th out of 12,415 executives tracked by ExecPay. In other words, Kapadia earned more than 45.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,808 out of 12,415 | 45th |
Division Manufacturing | 2,960 out of 5,505 | 46th |
Major group Chemicals And Allied Products | 1,311 out of 2,375 | 45th |
Industry group Drugs | 1,169 out of 2,096 | 44th |
Industry Pharmaceutical Preparations | 853 out of 1,546 | 45th |
Pay ratio
| Sandip Kapadia's Pay | $1,660,664 |
|---|---|
| Median Employee's Pay | $216,748 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Sandip Kapadia was $1,660,664.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.
The ratio of Sandip Kapadia's pay to the pay of median employee was therefore 8 to one.
Kapadia's colleagues
We found six more compensation records of executives who worked with Sandip Kapadia at Intercept Pharmaceuticals in 2021.
2021
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
2021
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
2021
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
2021
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
2021
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
2021
Rocco Venezia
Intercept Pharmaceuticals
Chief Financial Officer
News
May 2, 2022
April 8, 2022
April 27, 2021
April 29, 2020
April 30, 2019